A Study of Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT07570017 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

DLBCL

Interventions

DRUG: Rocbrutinib
DRUG: R-GemOx

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.